Navigation Links
Global Cystic Fibrosis Therapeutics Market 2016-2026
Date:1/6/2017

LONDON, Jan. 5, 2017 /PRNewswire/ -- Report Details

The latest report from business intelligence provider visiongain offers comprehensive analysis of the global cystic fibrosis market. Visiongain expects the global cystic fibrosis market to grow at a CAGR of 16.7% from 2016 to 2021. The global cystic fibrosis market is estimated to reach $7.7bn by 2021.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this 191-page report you will receive 113 tables, charts and graphs – all unavailable elsewhere.

The 191 page report provides clear detailed insight into the global cystic fibrosis market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

- Global Cystic Fibrosis market forecasts from 2016-2026

- Cystic Fibrosis submarket forecasts from 2016-2026 covering:
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
- Protein Transcription Modulators
- Pancreatic Enzyme Products (PEP)
- Other therapies

- Individual drug revenue forecasts from 2016-2026 by pharmacological classes:

- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators:
- Orkambi
- Kalydeco
- VX-661 + ivacaftor
- Second corrector/VX-661/ivacaftor

- Protein Transcription Modulators
- Pulmozyme
- QR-010
- Translarna

- Pancreatic Enzyme Products (PEP)
- Ceron

- Other therapies
- Cayston
- TOBI

- Revenue forecasts from 2016-2026 and discussion of relevant trends and developments in the leading national cystic fibrosis market

- Analysis of the key factors driving growth in the global, regional and country level of the Cystic Fibrosis Market from 2016-2026

- Patent and clinical trials information of the marketed and pipeline products for cystic fibrosis

- The dynamic of pricing, patient share and market share of the leading cystic fibrosis drugs in the US and Europe

- Discussion on selected leading companies marketing and developing cystic fibrosis drugs:
- Vertex Pharmaceuticals
- Roche
- AbbVie
- Gilead Sciences
- Novartis

Visiongain's study is intended for anyone requiring commercial analyses for the Cystic Fibrosis Market and leading companies. You find data, trends and predictions.

Download the full report: https://www.reportbuyer.com/product/4594353/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-cystic-fibrosis-therapeutics-market-2016-2026-300386902.html


'/>"/>
SOURCE ReportBuyer
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Anesthesia Disposables - Medical Equipment & Supplies
2. Eisai Acquires All Global Development And Marketing Rights For Chronic Weight Management Treatment Lorcaserin HCI
3. Global Ulcerative Colitis Partnering 2010-2016
4. Research and Markets - Global Peripheral Vascular Diagnostic Systems Market (2016-2020) - Product, Application & End User - Key Vendors are ArjoHuntleigh, Viasonix & Opto Circuits
5. Medical Devices: Technologies and Global Markets
6. Global Hospital Beds (Powered and Manual) - Medical Equipment & Supplies
7. Global Cholesterol Testing - Clinical Diagnostics
8. Global Home Medical Equipment Technologies Market Analysis & Trends - Industry Forecast to 2025
9. Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022
10. Global Audiological Devices - Medical Equipment & Supplies
11. Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2019)... ... 2019 , ... Xpediant Digital, the leader in DAM Integration ... VP of Product Development. Surace has spent his career developing products, building complex ... Technology & Distribution at HMN, where he led software development, data analytics, and ...
(Date:3/20/2019)... FALLS CHURCH, Va. (PRWEB) , ... March 20, ... ... solutions and services for Federal and state public health agencies, today announced the ... With more than 15 years of professional consulting and contracts management experience supporting ...
(Date:3/20/2019)... AUSTIN, Texas (PRWEB) , ... ... ... HealthCarePoint (HCP), today announced release of ground-breaking mechanisms specifically designed ... care, stay in compliance with local and international regulations and continue to ...
Breaking Medicine Technology:
(Date:3/20/2019)... (PRWEB) , ... March 20, 2019 , ... ... Medical systems are being developed with Wi-Fi connectivity to allow portable devices to ... heart and hypertension monitoring, glucose monitoring, and other wearable devices for home healthcare ...
(Date:3/20/2019)... ... March 20, 2019 , ... TSI Healthcare, ... (PM) and Electronic Health Record (EHR) solutions, received multiple top awards in the ... the fifth consecutive year TSI Healthcare has been honored by this selective international ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... pain from disc herniation's, degenerative disc disease, spinal stenosis, sciatica and numbness in ... location! , At Advanced Spine Joint and Wellness provider's work as a ...
(Date:3/20/2019)... CREEK, Calif. (PRWEB) , ... March 20, 2019 ... ... for the healthcare industry, announced today the launch of its mSource® Predictive Plan, ... customers the most complete insights. It gives purchased services teams the control to ...
(Date:3/20/2019)... ... March 20, 2019 , ... AutismOne has announced that Dr. Andrew Wakefield, an ... measles. Dr. Wakefield's presentation at the AutismOne 2019 Conference will address what herd immunity ... eras. The lecture will examine the consequences - real and potential - for vaccines ...
Breaking Medicine News(10 mins):